Infectious Diseases Infographic

Medicines in Development: Infectious Diseases

4,710 Clinical Trials Conducted By Massachusetts Research Centers Total Includes 491 Trials Conducted In Worcester Since 1999


Research in Massachusetts

Research in Nebraska

More Than 450 Innovative Medicines in Development for Rare Diseases

WASHINGTON, D.C. (October 7, 2013) – America’s biopharmaceutical research companies are developing 452 new medicines for rare diseases, including genetic disorders, neurological conditions, infectious diseases and autoimmune disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Rare Diseases - Big Impact

Medicines in Development for Rare Diseases

Alzheimer's: The Puzzle, The Partners, The Path Forward - Meeting Agenda

Alzheimer’s - The Puzzle, The Partners, The Path Forward

Alzheimer’s Disease (AD) is a debilitating neurodegenerative disease that currently afflicts more than 5 million people in the U.S. In an effort to catalyze progress in AD innovation and R&D, PhRMA, in partnership with the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, is hosting an all-day forum to convene top industry and academic scientists, patients, policymakers, and other stakeholders.


Subscribe to RSS - Innovation